PULMONARY ARTERY HYPERTENSION
Clinical trials for PULMONARY ARTERY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERY HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY ARTERY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes drug help PAH patients walk farther?
Symptom relief CompletedThis study tested whether metformin, a common diabetes drug, along with a text-message activity program, could help people with pulmonary artery hypertension (PAH) walk farther and feel better day-to-day. 73 adults with PAH took part. The goal was to see if these interventions im…
Matched conditions: PULMONARY ARTERY HYPERTENSION
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New MRI technique could make heart procedures safer and faster
Knowledge-focused CompletedThis study tests whether special low-energy MRI settings can make it safe to use guidewires during heart catheterization. Guidewires help position catheters but can heat up in standard MRI. Researchers will enroll 22 adults who need a right heart catheterization to see if this ap…
Matched conditions: PULMONARY ARTERY HYPERTENSION
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Researchers dive into why scleroderma and lung hypertension weaken the heart
Knowledge-focused CompletedThis study looked at 43 adults with scleroderma or unexplained pulmonary arterial hypertension (PAH) to understand why the right side of the heart weakens. Researchers collected blood and tissue samples during routine procedures and measured heart function over 6 months. The goal…
Matched conditions: PULMONARY ARTERY HYPERTENSION
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC